Priorities

Multidrug-Resistant Tb Will Rise In India, Says New Study

Multidrug-Resistant Tb Will Rise In India, Says New Study

by The Daily Eye Team May 15 2017, 12:54 pm Estimated Reading Time: 0 mins, 33 secs

A month after the Health Ministry set itself the target of eliminating tuberculosis (TB) by 2025, a new study in the medical journal Lancet says that India’s TB crisis is likely to get worse. According to the latest issue of the journal, Multidrug Resistant-Tuberculosis (MDR-TB), a version of the disease where patients do not respond to first-line drugs, will become more common than it is now. The report projects that, by 2040, the percentage of MDR-TB will make up 32.5% of all TB cases in Russia, 12.4% of the TB cases in India, 8.9% of the TB cases in the Philippines, and 5.7% of all TB cases in South Africa.

Read more at www.thehindu.com




Disclaimer: The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of thedailyeye.info. The writers are solely responsible for any claims arising out of the contents of this article.